跳至主要内容
临床试验/NL-OMON42529
NL-OMON42529已完成不适用

A Phase 1, Randomized, Placebo- and Active-Controlled, Double-Blind, Parallel, Electrocardiogram Study to Evaluate the Effect of VX-661 on the QT/QTc Interval in Healthy Subjects - VX15-661-010 QTc study

Vertex Pharmaceuticals0 个研究点目标入组 130 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male or female
  • 18-45 y, incl.
  • BMI 18.0 - 30.0

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study

研究者

相似试验

A Phase 1, Randomized, Placebo- and... | 临床试验